← Eichor
Study identifier: NCT07378670 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

DEfeating PEnile CAncer-2

Condition: Penile Cancer · Penile Neoplasms Malignant  ·  Sponsor: University Hospital Tuebingen

PhaseNA
Planned participants80
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

Open inguinal lymphadenectomy (O-ILAD) is the current standard of care for invasive staging and simultaneously the curative approach for patients with PeCa and elevated risk for or clinically detectable lymphatic disease in the groin. The high rate of complications of this surgical procedure, which are often mutilating and associated with a long-term convalescence, leads to a critical delay in initiation of adjuvant systemic therapy. Being in apprehension of these postsurgical adversities, physicians are often reluctant with indicating this procedure, thus depriving their patients of the vital prognosis-relevant care. In the sum, these obstacles inevitably result in inferior oncologic outcomes. Aiming to decrease postsurgical detrimental sequelae, several attempts to modify radicality of the technique, including inter alia a radioguided approach of sentinel lymph node resection, have been presented in the last decades. Unfortunately, utilization of the sentinel lymph node technique outside of a few highly specialized referral centers is prone to a significant false negativity, while other approaches are associated with inconsistent oncological and perioperative outcomes, hence precluding a general breakthrough in the surgical management of the groin lymph nodes. Thus, a high unmet medical need exists for the establishment of an approach with the lowest possible rate of complications and at the same time the optimal oncological safety. In this context, preliminary evidence fr…

This description comes directly from the study's public registry record.

Talk to the study team

Elizaveta Dimitrievski  ·  +4970712968257  ·  elizaveta.dimitrievski@med.uni-tuebingen.de

Annemarie Uhlig  ·  vertrag.uro-studien@med.uni-tuebingen.de

Always discuss trial participation with your own doctor first.

Locations (9)

Charité- Universitätsmedizin BerlinBerlin, GermanyNot Yet Recruiting
University Hospital Carl Gustav CarusDresden, GermanyNot Yet Recruiting
Universitätsklinikum ErlangenErlangen, GermanyNot Yet Recruiting
University Medical Center of Johannes Gutenberg-UniversityMainz, GermanyNot Yet Recruiting
Medical Faculty MannheimMannheim, GermanyNot Yet Recruiting
Ludwig Maximilian University HospitalMünchen, GermanyNot Yet Recruiting
University Medicine RostockRostock, GermanyNot Yet Recruiting
University Hospital TübingenTübingen, GermanyRecruiting
University Hospital UlmUlm, GermanyNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07378670